ALETHIOMICS
Alethiomics is a pre-clinical biotech company harnessing the power of single-cell multi-omic technology to discover and develop life-changing treatments for patients with blood cancer.
ALETHIOMICS
Industry:
Biotechnology Therapeutics
Founded:
2021-01-01
Address:
Headington, Oxfordshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.alethiomics.com
Total Employee:
1+
Status:
Active
Total Funding:
6 M GBP
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Tag Manager Google Analytics HSTS Amazon Content Delivery Network Global Site Tag Google Universal Analytics Typekit
Similar Organizations
Apeiron Biologics
Apeiron Biologics is a biotech company that focuses on the discovery and development of novel cancer immunotherapies.
BridGene Biosciences
BridGene Biosciences is a biotechnology company using cutting-edge chemoproteomic technology to discover and develop small molecules.
Casma Therapeutics
Casma Therapeutics is a biotechnology company harnessing the natural cellular process of autophagy to design new medicines.
STipe Therapeutics
STipe Therapeutics focuses on harnessing the innate immune system to battle cancer.
Current Employees Featured
Bethan Psaila Co-Founder @ Alethiomics
Co-Founder
Adam Mead Co-Founder @ Alethiomics
Co-Founder
Edward Ainscow Chief Scientific Officer @ Alethiomics
Chief Scientific Officer
Founder
Investors List
Oxford Science Enterprises
Oxford Science Enterprises investment in Seed Round - Alethiomics
Official Site Inspections
http://www.alethiomics.com Semrush global rank: 7.21 M Semrush visits lastest month: 859
- Host name: 198.185.159.145
- IP address: 198.185.159.145
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "Alethiomics"
Alethiomics
From single cells to novel targets We uncover new biology to discover and develop life changing treatments for patients with blood cancerSee details»
Alethiomics - Crunchbase Company Profile & Funding
Organization. Alethiomics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Alethiomics …See details»
Alethiomics - Oxford Science Enterprises
Alethiomics is a pre-clinical biotech company leveraging the power of single cell multi-omic analysis to identify novel drug targets and uncover new biology to design better treatments for patients with blood cancer. What Life Sciences. …See details»
Alethiomics - LinkedIn
Associate Director, R&D at Alethiomics Vladimir Kiselev Building Scalable Bioinformatics & AI Solutions | Cloud Infrastructure, Pipelines & Data Science Expert, Single-Cell, Drug DiscoverySee details»
ALETHIOMICS LIMITED Company Profile - Dun & Bradstreet
Alethiomics limited. d&b business directory home / business directory / professional, scientific, and technical services / scientific research and development services / united kingdom / oxford / …See details»
Alethiomics Ltd. - Oxford, United Kingdom - bionity.com
Alethiomics Ltd is a pre-clinical biotech company harnessing the power of single cell multi-omic technology to discover and develop life changing treatments for patients with blood cancer. A …See details»
Alethiomics - VentureRadar
Alethiomics aims to apply innovations in single-cell multi-omic analysis to the development of novel therapeutics for myeloproliferative neoplasms (MPNs). MPNs begin with mutations …See details»
ALETHIOMICS LIMITED overview - Find and update company …
Company Overview for ALETHIOMICS LIMITED (13509030) Filing history for ALETHIOMICS LIMITED (13509030) People for ALETHIOMICS LIMITED (13509030) Charges for …See details»
Introducing Alethiomics — BioEscalator
Feb 1, 2022 A spin-out from the University of Oxford, Alethiomics is built on a decade of world-leading research on blood cancers and breakthrough innovation in single-cell multi-omic …See details»
People - Alethiomics
Meet the Alethiomics Team. Professor Adam Mead. CO-FOUNDER. Adam is a Professor of Haematology and a member of the Radcliffe Department of Medicine at the University of …See details»
Alethiomics – using Artemis to hunt down blood cancers
Dec 12, 2024 Spin-out company Alethiomics, focused on the development of innovative treatments for blood cancers, is Oxford through-and-through. Founded by Clinician Scientists …See details»
Alethiomics - Funding, Financials, Valuation & Investors
Alethiomics is a biotech company harnessing the power of single-cell multi-omic technology to discover & develop treatment for blood cancer. New. Resources. ... How much funding has …See details»
Alethiomics - EU-Startups
Alethiomics is a pre-clinical biotech company harnessing the power of single-cell multi-omic technology to discover and develop life-changing treatments for patients with blood cancer. …See details»
Alethiomics – Startups.Bio
Feb 9, 2022 Alethiomics is an Oxford University spin-out applying innovations in single-cell multi-omic analysis to the development of novel therapeutics for myeloproliferative neoplasms …See details»
Contact — Alethiomics
Alethiomics is based at The BioEscalator, Oxford University's biotech incubator. Email: hello@alethiomics.com Address: Alethiomics Ltd., Innovation building, Old Road Campus, …See details»
Spin-out company Alethiomics launches — MRC Weatherall …
Dec 15, 2021 ‘The Alethiomics TARGET-seq platform simultaneously detects DNA mutations, the RNA transcriptome and cell surface proteins from individual cells to provide a holistic …See details»
Spin-out company Alethiomics launched | NIHR Oxford Biomedical …
Dec 17, 2021 Alethiomics aims to apply innovations in single-cell multi-omic analysis to the development of novel therapeutics for myeloproliferative neoplasms (MPNs). MPNs are a …See details»
Alethiomics - Contacts, Employees, Board Members, Advisors
Alethiomics is a biotech company harnessing the power of single-cell multi-omic technology to discover & develop treatment for blood cancer. ... Experience the new Crunchbase, powered …See details»
Spin-out company Alethiomics launches — Radcliffe Department …
Dec 15, 2021 ‘The Alethiomics TARGET-seq platform simultaneously detects DNA mutations, the RNA transcriptome and cell surface proteins from individual cells to provide a holistic …See details»
Our Science - Alethiomics
The Alethiomics TARGET-seq platform uses multi-omic information from single cells to provide a holistic understanding of disease, and more intelligent target identification. It is the only …See details»